Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 06 Aug 2026
Researchers say they’ve uncovered rare genetic mutations that may switch the body’s sweat signals into overdrive.
Read Full NewsAnjali Vaidya, MD, explains why echocardiography should inform right heart catheterization interpretation in pulmonary hypertension at CHEST 2026.
Samantha Pettigrew, MD, reviews HI-PEITHO, PRAGUE-26, and PEERLESS and how they shape intervention choices in intermediate-risk PE at CHEST 2026.
Updated data from Breakfree-2 study showed that treatment with a single zola-cel infusion achieved NEDA-3 in highly active relapsing multiple sclerosis and led to mostly stable disability in progressive multiple sclerosis.
Phase 3 data show the oral BTK inhibitor reduced annualized relapse rate by 35.2% and 31.2% vs teriflunomide, with no liver safety signal or Hy's Law cases.
At a NeurologyLive and Targeted Oncology Clinical Forum in Houston, Kevin J. Bielamowicz, MD, of Arkansas Children’s Hospital, discussed how incidental diagnosis and limited awareness of systemic therapy continue to delay care for patients with NF1-associated plexiform neurofibromas.
A secondary analysis of the BRIDGE-TNK trial found tenecteplase before thrombectomy improved functional outcomes in cardioembolic but not atherosclerotic stroke.
Test your neurology knowledge with NeurologyLive®'s weekly quiz series, featuring questions on a variety of clinical and historical neurology topics. This week's topic is recent advances in gene therapies.
1.
A new blood test greatly increases the ability to detect cancer.
2.
For MDS-Related Anemia, Telomerase Inhibitor Approved.
3.
Study: Pre-operative THP leads to pCR in 64% of early-stage HER2+ ER- breast cancer patients
4.
examining differences in the rates of breast reconstruction following mastectomies.
5.
Combination treatment may help cut lifelong ibrutinib for chronic lymphocytic leukemia patients
1.
Exercise Rehabilitation in Hematologic Disease Survivorship
2.
Understanding Mesenteric Masses: Symptoms, Diagnosis, and Treatment Options
3.
Understanding the Importance of Red Cell Distribution Width (RDW) in Blood Tests
4.
Advancements in Breast Cancer Treatment: From Chemotherapy to Immunotherapy
5.
A Review on Genetic Predispositions and Clinical Advancements of Multiple Myeloma Cancer
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part III
2.
Revolutionizing Treatment of ALK Rearranged NSCLC with Lorlatinib - Part I
3.
Pazopanib Takes Center Stage in Managing Renal Cell Carcinoma - Part II
4.
Hands-on Workshop: Hematology
5.
Should We Use DARA Up Front As First-Line Therapy in MM?
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge